UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 16, 2024

Accession Number:	0001104659-24-099792
Submission Type:	POS AM
CIK: 0001795579 Company Name: Calliditas Therapeutics AB File Number: 333-265881